pseudogynecomastia

Pseudogynecomastia is the appearance of male breast enlargement due to an excess of fatty tissue rather than proliferation of glandular tissue. It contrasts with true gynecomastia, in which enlargement results from glandular tissue growth, often related to hormonal changes, medications, or systemic conditions.

Causes and risk factors include obesity and increased chest fat, which can occur with overall weight gain or metabolic syndrome. The condition is usually bilateral and soft in consistency. Pseudogynecomastia can coexist with true gynecomastia, so accurate differentiation often requires clinical assessment.

Diagnosis is typically clinical. On examination, the chest appears soft and diffusely enlarged without a discrete, firm glandular mass. Palpation may reveal uniform fat rather than nodular tissue. Imaging such as ultrasound can help distinguish fat from glandular tissue; in uncertain cases, endocrinologic evaluation or mammography may be used to exclude pathology or true gynecomastia.

Management centers on lifestyle modification. Primary treatment is weight reduction through diet and exercise. In selected cases, liposuction or surgical contouring may be considered for cosmetic reasons. If there is any suspicion of true gynecomastia, evaluation for hormonal disorders, medication effects, or other underlying causes is indicated.

Prognosis is generally favorable with appropriate interventions. Weight loss can reduce the appearance of pseudogynecomastia, though fat distribution varies and persistent cases may require cosmetic procedures. Monitoring and addressing associated risk factors, such as obesity or metabolic syndrome, can improve overall health.